Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ivan Civettini"'
Autor:
Ivan Civettini, Laura Antolini, Filippo Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti‐Passerini
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9662-9667 (2023)
Abstract Introduction COVID‐19 pandemic had a considerable impact among haematological patients. On the other hand, the effect of this disease on patients (pts) affected by Chronic Myeloid Leukemia (CML) is not clearly defined. Objectives The prima
Externí odkaz:
https://doaj.org/article/3b937b9f937f44e088f8331dc79d9e7e
Autor:
Ivan Civettini, Laura Antolinni, Filippo Achille Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti-Passerini
Publikováno v:
HemaSphere, Vol 7, p e64239d9 (2023)
Externí odkaz:
https://doaj.org/article/a48ff53458f8468293991eba91f4abe9
Autor:
Ivan Civettini, Fabrizio Cavalca, Arianna Zappaterra, Stefano Crippa, Elena Agostani, Andrea Palasciano, Laura Antolinni, Federica Cocito, Carlo Gambacorti-Passerini
Publikováno v:
HemaSphere, Vol 7, p e27260d1 (2023)
Externí odkaz:
https://doaj.org/article/18134a2e953845a68f2764a0dbe46c34
Autor:
Federica Malighetti, Giulia Arosio, Chiara Manfroni, Mario Mauri, Matteo Villa, Beatrice Manghisi, Elena Inzoli, Giovanni Rindone, Giovanni P. M. Zambrotta, Ivan Civettini, Veronica Guglielmana, Daniele Ramazzotti, Giovanni Giudici, Silvia Bombelli, Roberto Perego, Rocco Piazza, Luca Mologni, Carlo Gambacorti-Passerini
Publikováno v:
HemaSphere, Vol 7, Iss 3, p e852 (2023)
Externí odkaz:
https://doaj.org/article/0bb1561356c44b59900289c5a5a83bde
Autor:
Ivan Civettini, Laura Antolini, Filippo Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti‐Passerini
Publikováno v:
Cancer Medicine. 12:9662-9667
Autor:
Elena Inzoli, Elena Crisà, Novella Pugliese, Ivan Civettini, Giuseppe Lanzarone, Andrea Castelli, Vincenzo Martinelli, Laura Montelisciani, Laura Antolini, Carlo Gambacorti‐Passerini, Elena Maria Elli
Publikováno v:
European Journal of Haematology. 110:354-361
Objectives: Erythropoiesis-stimulating agents (ESA) have an established role in treating anemia in hematological malignancies. However, their role, particularly biosimilar ESA (B-ESA), in myelofibrosis (MF) is not well established.Methods: This study
Publikováno v:
British journal of haematology.